Imagin Medical Inc. (IME)

Overview

Imagin Medical Inc. is a specialized urologic oncology company deeply engaged in the research, development, and commercialization of innovative medical devices within the bio-chemistry sector. Established in 1986 with its headquarters in Vancouver, Canada, the company is at the forefront of designing and introducing groundbreaking technologies aimed at the visualization and treatment of urologic cancers via minimally invasive procedures. Focusing primarily on bladder and prostate cancer, Imagin Medical Inc. holds a strategic license agreement with Lawrence Livermore National Security, LLC, for the development and commercialization of its flagship product, the i/Blue Imaging System.

Products and Services

• i/Blue Imaging System

This advanced medical device represents a significant leap forward in the detection of bladder cancer. With its proprietary optics and light sensors, the i/Blue Imaging System offers enhanced visualization capabilities that allow for more efficient and accurate diagnosis. By leveraging a combination of innovative technology, the system is designed to improve the detection rate of bladder cancers, which is crucial for timely and effective treatment.

• enCage Coil

A state-of-the-art disposable precision ablation device, the enCage Coil is specifically designed for the focal therapy treatment of prostate cancer. It signifies a pivotal advance in prostate cancer care, offering a minimally invasive option that targets cancer cells with precision, thereby minimizing damage to surrounding healthy tissues. This focus on focal therapy is reflective of current trends in cancer care that prioritize targeted treatments over more invasive traditional procedures.